Universe · entity

Stonepine Capital Management, LLC

Institutional manager (13F) · CIK 1440771
13F holdings · as of 2026-03-31 · top 50 · reported portfolio $111M
#IssuerValueShares
1VERASTEM INC$18M3,302,300
2TENAX THERAPEUTICS INC$16M975,200
3EVOLUS INC$7M1,759,091
4ADMA BIOLOGICS INC$7M740,000
5CAMP4 THERAPEUTICS CORP$6M1,389,622
6NEKTAR THERAPEUTICS$6M85,000
7ZEVRA THERAPEUTICS INC$4M480,000
8CORBUS PHARMACEUTICALS HLDGS$4M383,462
9ABEONA THERAPEUTICS INC$3M746,587
10KAZIA THERAPEUTICS LTD$3M345,179
11AN2 THERAPEUTICS INC$2M713,845
12SOL-GEL TECHNOLOGIES LTD$2M27,778
13XOMA ROYALTY CORPORATION$2M69,500
14AYTU BIOPHARMA INC$2M792,289
15CURIS INC$2M3,726,406
16TELA BIO INC$2M2,617,252
17INHIBIKASE THERAPEUTICS INC$2M957,202
18CRESCENT BIOPHARMA INC.$2M85,000
19ADICET BIO INC$2M221,955
20X4 PHARMACEUTICALS INC$1M335,309
21OKYO PHARMA LTD$1M850,000
22HERON THERAPEUTICS INC$1M1,402,191
23PULMONX CORP$991k768,288
24IN8BIO INC$982k663,412
25SURROZEN INC$961k33,005
26CYTOMX THERAPEUTICS INC.$940k200,000
27PMV PHARMACEUTICALS INC$878k708,102
28BIOAGE LABS INC$875k50,000
29CONNECT BIOPHARMA HLDGS LTD$812k310,000
30RADIOPHARM THERANOSTICS LTD$739k51,000,000
31MAXCYTE INC$706k1,004,673
32CODEXIS INC$681k417,994
33BOUNDLESS BIO INC$657k597,682
34CYBIN INC$643k134,060
35ZENTALIS PHARMACEUTICALS INC$630k269,100
36PASITHEA THERAPEUTICS CORP$617k831,301
37SATELLOS BIOSCIENCE INC$563k100,000
38PHATHOM PHARMACEUTICALS INC$556k50,010
39ONKURE THERAPEUTICS INC$549k132,578
40XILIO THERAPEUTICS INC$540k64,162
41VERRICA PHARMACEUTICALS INC$528k99,735
42CANDEL THERAPEUTICS INC$502k102,500
43PRECISION OPTICS CORP INC MA$439k100,000
44QUOIN PHARMACEUTICALS LTD$353k53,460
45ESTABLISHMENT LABS HLDGS INC$341k6,000
46UPSTREAM BIO INC$315k35,000
47OPUS GENETICS INC$313k68,688
48ARVINAS INC$292k27,500
49PLIANT THERAPEUTICS INC$283k224,650
50JANUX THERAPEUTICS INC$278k20,000
All filings on EDGAR ↗

Source: sec_edgar_13f · public regulatory · retrieved 2026-06-29. Public SEC data; no contact information.